Leaflet: information for the user
Pramep 300 mg hard capsules EFG
Pregabalin
Read this leaflet carefully before you start taking this medicine, as it contains important information for you.
- Keep this leaflet, as you may need to read it again.
If you have any questions, consult your doctor or pharmacist.
This medicine has been prescribed for you only, and you must not give it to others even if they have the same symptoms as you, as it may harm them.
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
Pramep belongs to a group of medications used for the treatment of epilepsy, peripheral and central neuropathic pain, and generalized anxiety disorder (GAD) in adults.
Peripheral and central neuropathic pain:Pramep is used for the treatment of chronic pain caused by nerve damage. There are various diseases that can cause peripheral neuropathic pain, such as diabetes or herpes. The pain sensation could be described as heat, burning, pulsating pain, stabbing pain, acute pain, spasms, continuous pain, numbness, tingling, and pins and needles sensation. Peripheral and central neuropathic pain could also be associated with mood changes, sleep disturbances, fatigue (tiredness), and can affect physical and social activity and overall quality of life.
Epilepsy:Pramep is used in the treatment of certain types of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe Pramep to treat epilepsy when your current treatment does not control the disease. You must take Pramep in addition to your current treatment. Pramep should not be administered alone, but always used in combination with other antiepileptic treatments.
Generalized anxiety disorder:Pramep is used in the treatment of generalized anxiety disorder (GAD). The symptoms of GAD are excessive and prolonged anxiety and worry that are difficult to control. GAD can also produce restlessness or feeling of excitement or nervousness, feeling easily fatigued (tired), difficulty concentrating or feeling mentally blank, irritability, muscle tension, or sleep disturbances. This is different from the stress and tensions of everyday life.
Warnings and precautions
Consult your doctor or pharmacist before starting to take pregabalin.
Dependence
Some people may become dependent on pregabalin (need to continue taking the medication). They may experience withdrawal effects when they stop using pregabalin (see section 3, "How to take Pramep" and "If you interrupt treatment with Pramep"). If you are concerned that you may become dependent on pregabalin, it is essential to consult your doctor.
If you notice any of the following signs while taking pregabalin, it could be a sign that you have become dependent:
If you notice any of these signs, talk to your doctor to analyze the best plan of care for you, including when it is appropriate to stop treatment and how to do it safely.
Children and adolescents
The safety and efficacy of pregabalin have not been established in children and adolescents (under 18 years), so pregabalin should not be used in this age group.
Other medications and Pramep
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Pramep and certain medications may influence each other (interactions). When pregabalin is taken with certain medications that have a sedative effect (including opioids), pregabalin may potentiate those effects, and may lead to respiratory failure, coma, and death. The degree of dizziness, somnolence, and decreased concentration may increase if pregabalin is taken with other medications that contain:
Oxycodone - (used as an analgesic)
Lorazepam - (used to treat anxiety)
Alcohol
Pregabalin can be taken with oral contraceptives.
Taking Pramep with food, drinks, and alcohol
The pregabalin capsules can be taken with or without food.
It is recommended not to take alcohol during treatment with this medication.
Pregnancy and breastfeeding
You should not take this medication during pregnancy or lactation, unless your doctor has indicated otherwise. The use of pregabalin during the first 3 months of pregnancy may cause congenital anomalies in the fetus that require medical treatment. In a study that reviewed data from women in Nordic countries who took pregabalin during the first 3 months of pregnancy, 6 out of 100 babies had such congenital anomalies. This contrasts with 4 out of 100 babies born to women not treated with pregabalin in the study. The anomalies included facial clefts, eyes, nervous system (including the brain), kidneys, and genitals.
A reliable contraceptive method should be used in women of childbearing age. If you are pregnant or breastfeeding, believe you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
Pregabalin may cause dizziness, somnolence, and decreased concentration. You should not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know if this medication affects your ability to perform these activities.
Pramep contains lactose
If your doctor has indicated that you have a lactose intolerance, consult with them before taking this medication.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Do not take a dose greater than the one prescribed to you.
Your doctor will determine the appropriate dose for you.
Peripheral and central neuropathic pain, epilepsy, or generalized anxiety disorder:
If you estimate that the action of pregabalin is too strong or too weak, inform your doctor or pharmacist.
Patients over 65 years old
If you are a patient over 65 years old, take this medication normally, except if you have kidney problems.
Patients with kidney problems
Your doctor may prescribe a different dosing regimen and/or different doses if you have kidney problems.
Administration form
Pramep is exclusively for oral use.
Swallow the capsule whole with water.
Treatment duration
Continue taking pregabalin until your doctor tells you to stop.
If you take more Pramep than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested. As a result of taking more pregabalin than you should, you may feel drowsy, confused, agitated, or restless. Seizures and loss of consciousness (coma) have also been reported.
If you forget to take Pramep
It is essential to take the pregabalin capsules regularly at the same time every day. If you forget to take a dose, take it as soon as you remember, unless it is time for the next dose. In that case, continue with the next dose normally. Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Pramep
Do not stop taking pregabalin unless your doctor tells you to. If you are going to stop treatment, this should be done gradually over a minimum of one week.
Once the treatment with pregabalin is completed, whether it is long-term or short-term, you should know that you may experience certain adverse effects called withdrawal effects. These include sleep problems, headaches, nausea, anxiety, diarrhea, flu-like symptoms, seizures, nervousness, depression, thoughts of self-harm or suicide, pain, sweating, and dizziness. These symptoms may appear more frequently or severely if you have been taking this medication for a longer period. If you experience withdrawal effects, consult your doctor.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may cause side effects, although not everyone will experience them.
If you experience swelling in the face or tongue, or if your skin becomes red and forms blisters or peels, you should seek immediate medical attention.
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency not known: cannot be estimated from available data:
Once a short- or long-term treatment with pregabalin has been completed, you should know that you may
experience certain side effects, called withdrawal effects (see "If you stop taking Pramep").
Certain side effects, such as drowsiness, may be more frequent since patients with spinal cord injury may be taking other medications to treat, for example, pain or spasticity (tense or rigid muscles), with side effects similar to those of pregabalin, so the intensity of these side effects may increase when taken together.
A post-marketing adverse reaction has been reported: difficulty breathing, shallow breathing.
Reporting of adverse effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and blister after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
The active ingredient is pregabalin. Each hard capsule contains 300 mg of pregabalin.
The other components are lactose monohydrate, pregelatinized cornstarch, talc, gelatin, titanium dioxide (E-171), iron oxide red (E-172).
Appearance of the product and content of the packaging
Hard white and orange capsules (approximately 22 mm in size).
Pramep 300 mg is available in a packaging size made of PVC with an aluminum foil: 56 and 100 capsules.
Only some packaging sizes may be marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
STADA, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona)
Spain
Responsible for manufacturing
STADA Arzneimittel AG
Stadastrasse 2-18
61118 Bad Vilbel
Germany
or
Centrafarm Services B.V.
Nieuwe Donk 9
NL-4879 AC Etten-Leur
Netherlands
or
Lamp San Prospero S.p.a.
Via Della Pace, 25/A
41030 San Prospero (MO)
Italy
Last review date of this leaflet:January 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.